Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 9, 2018
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
Wed, August 8, 2018
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
Madhu Kumar Maintained (ARWR) at Hold with Increased Target to $18 on, Aug 8th, 2018
Madhu Kumar of B. Riley Securities, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $12 to $18 on, Aug 8th, 2018.
Madhu has made no other calls on ARWR in the last 4 months.
There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Madhu's Rating of Hold.
This is the rating of the analyst that currently disagrees with Madhu
- Elemer Piros of "Cantor Fitzgerald" Upgraded from Hold to Buy on, Wednesday, May 9th, 2018
